Quantcast
Last updated on April 23, 2014 at 10:33 EDT

Latest ICU Medical Inc. Stories

2012-05-03 02:32:03

NEW ORLEANS, May 3, 2012 /PRNewswire-FirstCall/ -- ICU Medical, Inc. (NASDAQ: ICUI) today announced that two studies presented this week at the 37th Annual Congress of the Oncology Nursing Society (ONS) in New Orleans show that the company's ChemoClave(TM) needlefree closed system transfer device (CSTD) protects nurses from accidental exposure to hazardous chemotherapy drugs while increasing nurse satisfaction and perceptions of safety. The ChemoClave system is the world's...

2011-12-13 11:08:00

SAN CLEMENTE, Calif., Dec. 13, 2011 /PRNewswire/ -- ICU Medical, Inc. (NASDAQ: ICUI) announced that a clinical study presented at the American Society of Nephrology's (ASN) Kidney Week 2011 showed the Tego(®) needlefree hemodialysis connector can decrease heparin use and reduce costs for dialysis clinics. As the world's first and only needlefree connector FDA-cleared for use in hemodialysis applications, the Tego connector provides a cost effective...

2011-11-15 13:04:00

SAN CLEMENTE, Calif., Nov. 15, 2011 /PRNewswire/ -- ICU Medical, Inc. (NASDAQ: ICUI) today announced it has been awarded a 36-month contract with Novation for its full line of Critical Care products, including hemodynamic monitors and catheters, disposable pressure transducers, and in-line blood sampling systems. Effective January 1, 2012, the new agreement allows the members served by Novation to take advantage of special pricing and terms pre-negotiated by Novation. Novation is the...

2011-11-08 12:01:00

SAN CLEMENTE, Calif., Nov. 8, 2011 /PRNewswire/ -- ICU Medical, Inc. (NASDAQ: ICUI) today announced that a study presented this past weekend at the 36th annual meeting of the California Society of Health-System Pharmacists (CSHP) in Anaheim, CA has shown that the company's ChemoClave® closed system transfer device (CSTD) designed to keep pharmacists, nurses and patients safe from accidental exposure to hazardous drugs is more affordable for hospitals to implement than any...

2011-10-04 06:00:00

SAN JOSE, Calif., Oct. 4, 2011 /PRNewswire/ -- ICU Medical, Inc. (NASDAQ: ICUI) announced it is launching the Neutron((TM)) needlefree catheter patency device with constant neutral pressure today at the Association for Vascular Access Annual Scientific Meeting in San Jose, CA. Neutron is the world's first and only device with FDA 510k clearance to claim the ability to prevent fluid displacement during an IV bag run-dry, infusion pump stop, or patient vascular pressure changes caused by...

2011-04-14 11:37:00

SAN CLEMENTE, Calif., April 14, 2011 /PRNewswire/ -- ICU Medical, Inc. (NASDAQ: ICUI) today announced it has been awarded a 36-month contract with Premier Purchasing Partners, L.P., the group purchasing unit of Premier Inc., for its hemodynamic monitoring products, which are mostly used in the critical care setting. Effective July 1, 2011, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier. In addition,...

2011-04-04 11:45:00

SAN CLEMENTE, Calif., April 4, 2011 /PRNewswire/ -- ICU Medical, Inc. (NASDAQ: ICUI) today announced that three different clinical studies presented at the Annual Scientific Meeting of the Society for Healthcare Epidemiology of America (SHEA) April 1-4 in Dallas showed that the MicroCLAVE neutral displacement needleless connector helps significantly reduce the risk of bacterial contamination and limit the incidence of hospital-acquired bloodstream infection when used in connection with an...

2011-03-31 07:00:00

SAN CLEMENTE, Calif., March 31, 2011 /PRNewswire-FirstCall/ -- ICU Medical, Inc. (Nasdaq: ICUI) today announced that it will initiate the full market release of the MicroCLAVE Clear Neutral Displacement Needlefree Connector at the Annual Scientific Meeting of the Society for Healthcare Epidemiology of America (SHEA) April 1-4 in Dallas. MicroCLAVE Clear allows clinicians to visualize the fluid path, verifying effective flushing of the patient catheter after use with blood and medications...

2010-08-03 18:07:00

SAN CLEMENTE, Calif., Aug. 3 /PRNewswire-FirstCall/ -- ICU Medical, Inc. (Nasdaq: ICUI), a worldwide leader in the development, manufacture and sale of proprietary, disposable medical connection systems for use in vascular therapy applications, today confirmed that it has received FDA 510-k clearance for the Neutron(TM) Neutral-Pressure Needleless Connector. The new generation connector incorporates patented technology from ICU Medical that is designed to prevent all types of blood reflux...

2010-04-07 09:00:00

WINNIPEG, April 7 /PRNewswire/ - IV Automation is becoming an increasingly comprehensive technology after medical device company Intelligent Hospital Systems validated ICU Medical Inc.'s ChemoCLAVE(TM) Bag Spike for use with RIVA (Robotic IV Automation System) - a self-contained unit for filling IV syringes and bags. In addition to RIVA's proven effectiveness in enhancing patient safety, expediting the compounding process and reducing waste and technicians' exposure to a multitude of drug...